PAVM PAVmed Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: PAVM

Price (delayed)

$3.9875

Market cap

$31.88M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$16.32

Enterprise value

$45.17M

?
Relative Growth: Rel. Growth: 18
Relative Strength: Rel. Strength: 6
Relative Valuation: Rel. Valuation: 1
Relative Profitability: Rel. Profitability: 4

PAVmed Inc. is a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors. Its majority-owned subsidiary, Veris Health Inc., is a digital health company ...

Highlights
PAVM's gross margin is up by 2.9% since the previous quarter
PAVM's quick ratio has surged by 145% year-on-year but it is down by 47% since the previous quarter
The net income has dropped by 117% year-on-year but it has increased by 35% since the previous quarter
The debt has soared by 83% YoY
The equity has declined by 11% since the previous quarter and by 7% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: http://www.pavmed.com
Peers: OBIO OM

Key stats

What are the main financial stats of PAVM

PAVM stock price

How has the PAVmed stock price performed over time
Intraday
-4.66%
1 week
1.72%
1 month
-22.95%
1 year
-69.3%
YTD
-39.77%
QTD
-32.87%

Financial performance

How have PAVmed's revenue and profit performed over time
Revenue
$112,000
Gross profit
-$247,000
Operating income
-$26.7M
Net income
-$12.09M
Gross margin
-220.5%
Net margin
-10,794.6%
The net income has dropped by 117% year-on-year but it has increased by 35% since the previous quarter
PAVmed's revenue has plunged by 89% YoY but it has increased by 32% from the previous quarter
The net margin has soared by 51% from the previous quarter
PAVM's gross profit is up by 49% year-on-year but it is down by 28% since the previous quarter

Price vs fundamentals

How does PAVM's price correlate with its fundamentals

Growth

What is PAVmed's growth rate over time

Valuation

What is PAVmed stock price valuation
PAVM P/E details
P/E
N/A
P/B
0.83
P/S
223.21
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
403.28
The EPS has dropped by 108% year-on-year but it has soared by 57% since the previous quarter
The equity has declined by 11% since the previous quarter and by 7% year-on-year
The stock's price to book (P/B) is 9% more than its last 4 quarters average of 0.8
PAVmed's revenue has plunged by 89% YoY but it has increased by 32% from the previous quarter
The stock's price to sales (P/S) is 16% less than its 5-year quarterly average of 277.5 but 3.6% more than its last 4 quarters average of 226.0

Efficiency

How efficient is PAVmed business performance
PAVM's return on assets has dropped by 129% year-on-year but it is up by 26% since the previous quarter
The ROE has shrunk by 116% YoY but it rose by 26% QoQ
The company's return on invested capital has shrunk by 114% YoY but it rose by 39% QoQ
The ROS has soared by 51% since the previous quarter

Dividends

What is PAVM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PAVM.

Financial health

How did PAVmed financials performed over time
The total assets is 92% more than the total liabilities
PAVM's quick ratio has surged by 145% year-on-year but it is down by 47% since the previous quarter
PAVmed's current ratio has surged by 129% YoY but it has decreased by 41% QoQ
The debt is 51% less than the equity
PAVM's debt to equity has surged by 96% year-on-year and by 14% since the previous quarter
The debt has soared by 83% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.